BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34335968)

  • 1. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization.
    Mukha A; Kahya U; Dubrovska A
    Autophagy; 2021 Nov; 17(11):3879-3881. PubMed ID: 34486482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.
    Le Grand M; Mukha A; Püschel J; Valli E; Kamili A; Vittorio O; Dubrovska A; Kavallaris M
    Theranostics; 2020; 10(14):6411-6429. PubMed ID: 32483461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
    Shen YA; Hong J; Asaka R; Asaka S; Hsu FC; Suryo Rahmanto Y; Jung JG; Chen YW; Yen TT; Tomaszewski A; Zhang C; Attarwala N; DeMarzo AM; Davidson B; Chuang CM; Chen X; Gaillard S; Le A; Shih IM; Wang TL
    Cancer Res; 2020 Oct; 80(20):4514-4526. PubMed ID: 32859605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
    Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
    Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.
    He Z; Gao Y; Li T; Yu C; Ou L; Luo C
    Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35191516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
    Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
    Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
    Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
    Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
    Xu L; Yin Y; Li Y; Chen X; Chang Y; Zhang H; Liu J; Beasley J; McCaw P; Zhang H; Young S; Groth J; Wang Q; Locasale JW; Gao X; Tang DG; Dong X; He Y; George D; Hu H; Huang J
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.
    Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
    Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
    Ganguly K; Bhatia R; Rauth S; Kisling A; Atri P; Thompson C; Vengoji R; Ram Krishn S; Shinde D; Thomas V; Kaur S; Mallya K; Cox JL; Kumar S; Batra SK
    Gastroenterology; 2022 Jan; 162(1):253-268.e13. PubMed ID: 34534538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
    Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase.
    Kamarajan P; Rajendiran TM; Kinchen J; Bermúdez M; Danciu T; Kapila YL
    J Proteome Res; 2017 Mar; 16(3):1315-1326. PubMed ID: 28168879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
    Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
    J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia.
    Matschke J; Riffkin H; Klein D; Handrick R; Lüdemann L; Metzen E; Shlomi T; Stuschke M; Jendrossek V
    Antioxid Redox Signal; 2016 Jul; 25(2):89-107. PubMed ID: 27021152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.